Kala Bio KALA
NASDAQ KALA
$0.43 +0.00 (+0.28%)
As of: Oct 1, 2026 · 1:06 PM EDT

Kala Bio (KALA) Revenue (2019 - 2022)

Updated

Kala Bio (KALA) posted Revenue of $3.89 million for FY2022, down 65.4% from $11.24 million in FY2021.

Analysis

Kala Bio (KALA) Revenue (2019 - 2022) Analysis & Trends

Since FY2015, Kala Bio has reported Revenue for 5 years.

  • Annual Revenue shows a three-year compound annual growth rate of -13.8% (FY2019 to FY2022).
  • The FY2022 figure stands as the lowest annual Revenue since FY2015.
  • Business Quant data shows KALA's Revenue at $11.24 million in FY2021 (+76.7%), $6.36 million in FY2020 (+4.7%) and $6.07 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Kala Bio 6.57 Mn 6.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 420,000.00
Jun 30, 2022 2.10 Mn
Mar 31, 2022 1.37 Mn
Dec 31, 2021 1.86 Mn
Sep 30, 2021 3.07 Mn
Jun 30, 2021 3.05 Mn
Mar 31, 2021 3.27 Mn
Dec 31, 2020 2.24 Mn
Sep 30, 2020 2.22 Mn
Jun 30, 2020 833,000.00
Mar 31, 2020 1.07 Mn
Dec 31, 2019 1.18 Mn
Sep 30, 2019 1.45 Mn
Jun 30, 2019 2.06 Mn
Mar 31, 2019 1.39 Mn
API Access

Kala Bio Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KALA&period=max&api_key=YOUR_API_KEY